Table 1 Baseline data of patients grouped by OMT status
From: Current trends in optimal medical therapy after PCI and its influence on clinical outcomes in China
Total (n = 3588) | OMT (n = 1299) | Non-OMT (n = 2289) | P value | |
|---|---|---|---|---|
Demographics | ||||
Age (years) | 62.20 ± 9.72 | 62.69 ± 9.40 | 61.93 ± 9.89 | 0.025 |
≥ 65 years | 1479 (41.2) | 560 (43.1) | 919 (40.1) | 0.083 |
Male | 2298 (64.0) | 815 (62.7) | 1483 (64.8) | 0.219 |
BMI (kg/m2) | 25.74 ± 3.23 | 25.93 ± 3.27 | 25.63 ± 3.20 | 0.009 |
Medical insurance | < 0.001 | |||
No medical insurance | 609 (17.0) | 132 (10.2) | 477 (20.8) | |
Basic medical insurance | 1411 (39.3) | 436 (33.6) | 975 (42.6) | |
Employees medical insurance | 1568 (43.7) | 731 (56.3) | 837 (36.6) | |
Education | < 0.001 | |||
Primary | 1088 (30.3) | 334 (25.7) | 754 (32.9) | |
Intermediate | 1060 (29.5) | 310 (23.9) | 750 (32.8) | |
Advanced | 1440 (40.1) | 655 (50.4) | 785 (34.3) | |
Current smoker | 1444 (40.2) | 537 (41.3) | 907 (39.6) | 0.314 |
History | ||||
Prior PCI | 878 (24.5) | 347 (26.7) | 531 (23.2) | 0.019 |
Prior CABG | 54 (1.5) | 21 (1.6) | 32 (1.4) | 0.602 |
Prior MI | 475 (13.2) | 185 (14.2) | 290 (12.7) | 0.182 |
Comorbidities | ||||
Hypertension | 2305 (64.2) | 1023 (78.8) | 1282 (56.0) | < 0.001 |
Hyperlipidemia | 1494 (41.6) | 591 (45.5) | 903 (39.4) | < 0.001 |
Diabetes | 1828 (50.9) | 724 (55.7) | 1104 (48.2) | < 0.001 |
Stroke | 287 (8.3) | 117 (9.0) | 180 (7.9) | 0.232 |
CHF | 249 (6.9) | 80 (6.2) | 169 (7.4) | 0.165 |
Number | < 0.001 | |||
0 | 416 (11.6) | 86 (6.6) | 330 (14.4) | |
1 | 1021 (28.5) | 313 (24.1) | 708 (30.9) | |
≥ 2 | 2151 (59.9) | 900 (69.3) | 1251 (54.7) | |
Diagnosis | ||||
ACS | 3195 (89.0) | 1160 (89.3) | 2035 (88.9) | |
Number of coronary lesions | 0.003 | |||
Single | 1013 (28.2) | 328 (25.3) | 685 (29.9) | |
Multiple (≥ 2 branches or left main obstructive) | 2575 (71.8) | 971 (74.7) | 1604 (70.1) | |
PLT (10^9/L) | 223.38 ± 55.89 | 224.26 ± 56.60 | 222.88 ± 55.49 | 0.479 |
HGB (g/L) | 136.69 ± 15.42 | 136.61 ± 15.42 | 136.73 ± 15.42 | 0.822 |
FBG (mmol/L) | 7.60 ± 2.76 | 7.83 ± 2.79 | 7.48 ± 2.74 | < 0.001 |
SCR (µmol/L)a | 67(57,78) | 68(58,80) | 67(57,77) | 0.016 |
LDL-C (mmol/L)a | 2.72(2.11,3.33) | 2.70(2.13,3.32) | 2.72(2.11,3.33) | 0.436 |
Prescription | ||||
The number of types of pills | 5.28 ± 1.43 | 5.73 ± 1.20 | 5.03 ± 1.48 | < 0.001 |